Assignee
KANGSTEM BIOTECH CO LTD
KR·4 granted patents·14 pending applications·0 citations·filing 2016–2025
Top patents by PatentIndex Score
18 records- 0170US2024075072A1Composition for preventing or treating inflammatory diseases, containing, as active ingredient stem cells overexpressing sod3KANGSTEM BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 0269US2025321225A1Skin damage organoid model and drug screening method using the sameKANGSTEM BIOTECH CO LTD·Filed 2024·Application pending·0 cites
- 0365US2023321153A1Method for preparing injectable injection composition derived from animal cartilage, and use thereofKANGSTEM BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 0465US2026083780A1Complex for promoting cartilage differentiation comprising cartilage cell-free crush and stem cell and use thereofKANGSTEM BIOTECH CO LTD·Filed 2025·Application pending·0 cites
- 0559US11730766B2Composition for preventing or treating inflammatory diseases, containing, as active ingredient, stem cells overexpressing SOD3KANGSTEM BIOTECH CO LTD·Filed 2016·Granted Aug 22, 2023·0 cites·6 claims
- 0659US2025388863A1Method for culturing stem cells using microcarrierKANGSTEM BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 0759US2024299460A1Method for preparing injectable injection composition derived from animal cartilage, and use thereofKANGSTEM BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 0856US2024366679A1Method for treating immune diseases using calcineurin inhibitor and stem cellsKANGSTEM BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 0954US2026002122A1Stem cell culture method using serum-free mediumKANGSTEM BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 1053US2023392127A1Method for construction of atopic dermatitis model by using pluripotent stem cell-derived skin organoidKANGSTEM BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1151US12350295B2Complex for promoting cartilage differentiation comprising cartilage cell-free crush and stem cell and use thereofKANGSTEM BIOTECH CO LTD·Filed 2017·Granted Jul 8, 2025·0 cites·5 claims
- 1250US12589116B2Method for producing umbilcal cord blood-derived stem cell with enhanced efficacyKANGSTEM BIOTECH CO LTD·Filed 2020·Granted Mar 31, 2026·0 cites·10 claims
- 1348US2021254005A1Off-the-shelf stem cell and immune cell, and a pharmaceutical composition including the sameKANGSTEM BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1446US2021222127A1Hla gene-deleted human induced pluripotent stem cell-derived mesenchymal stem cells and preparation method thereofKANGSTEM BIOTECH CO LTD·Filed 2019·Application pending·0 cites
- 1541US2019111108A1Composition Including GDF11 and Use ThereofKANGSTEM BIOTECH CO LTD·Filed 2016·Application pending·0 cites
- 1640US2019133922A1Stem Cell-Derived Exosomes Containing a High Amount of Growth FactorsKANGSTEM BIOTECH CO LTD·Filed 2017·Application pending·0 cites
- 1738US2023285635A1Method for producing highly functional artificial organs using aptamersKANGSTEM BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1820USD1054587SStorage box for vial bottlesKANGSTEM BIOTECH CO LTD·Filed 2022·Granted Dec 17, 2024·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when KANGSTEM BIOTECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →